Baxter International Inc.
BAXHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframeBaxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. With a market capitalization of $13.35B, it sits in large-cap territory. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals.
Market Cap
$13.35B
Beta
0.59
P/E (TTM)
—
P/E (Fwd)
12.68
EPS (TTM)
$-1.88
EPS (Fwd)
$2.04
ROE
-14.4%
ROA
2.9%
Cash
$2.15B
Total Debt
$9.67B
Free CF
$1.00B
52W Change
5.6%
Annual Financials
Cash vs Debt
Where BAX stands vs its 150-day and 200-day moving averages
As of the August 19, 2026 close, BAX finished 28.67% above its 150-day moving average ($20.16) and 30.88% above its 200-day moving average ($19.82). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is BAX overbought or oversold?
At the August 19, 2026 close, BAX's RSI(14) was 56.5, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Baxter International Inc. carries $9.67B in total debt against $2.15B in cash reserves — debt is roughly 4.5x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $1.00B, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at -14.4%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.9% is on the lower side, which is common in asset-heavy industries. Revenue has been uneven over recent years, ranging from $10.06B to $11.24B.
The relatively low beta of 0.59 suggests BAX is a less volatile holding compared to the broader index. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Baxter International Inc.'s trajectory.